tradmap

BSX Boston Scientific

$45.28 +0.64%

S&P 500 Companies

Held by SPYVOOIVV

Healthcare · Surgical & Medical Instruments & Apparatus

Boston Scientific (BSX) is a healthcare company in the Surgical & Medical Instruments & Apparatus industry, with a market capitalization of $67.3 billion. Shares last traded at $45.28, 58.6% below their 52-week high. Over the past year the stock is down 55.5%. BSX trades at a price-to-earnings ratio of 23.27, below the Surgical & Medical Instruments & Apparatus median of 28.73. Net profit margin is 14.4%, above the peer median of -7.6%. Revenue grew 19.9% year over year.

Market Cap
$67.3B
Shares Out
1.49B
EPS (TTM)
$3.82
P/E Ratio
11.85
P/S Ratio
3.35
P/B Ratio
2.60
Dividend / Share
Dividend Yield
52-Week High
$109.47
52-Week Low
$44.45
Volume
1.7M
Avg Vol (3m)
1.4M

Performance

1W
-4.02%
1M
-20.32%
3M
-35.31%
6M
-51.28%
YTD
-52.19%
1Y
-55.48%

Daily candles · volume · SMA(20)/SMA(50) · Databento EQUS.MINI.

Technicals

RSI (14)
26.76
SMA (50)
$54.96
SMA (200)
$81.22
Price vs SMA50
-17.61%
Price vs SMA200
-44.25%
ATR (14)
$1.70

Financials

Revenue
$20.1B
Net Income
$2.9B
Gross Margin
69.0%
Operating Margin
18.0%
Net Margin
14.4%
Return on Equity
11.2%
Return on Assets
6.5%
Current Ratio
1.90
Debt / Equity
0.19
Revenue Growth (YoY)
+19.9%

Latest reported annual period ending 2025-12-31 · SEC EDGAR/XBRL.

Recent earnings

PeriodEPS (diluted)Reported
Q1 2026 $0.90 2026-05-01
FY 2025 $1.94 2026-02-17
Q3 2025 $1.49 2025-11-03
Q2 2025 $0.98 2025-08-01
Q1 2026 $0.45 2026-05-01
FY 2025 $1.25 2026-02-17

Full earnings history →

Surgical & Medical Instruments & Apparatus peers

BSX vs 14 industry peers (Surgical & Medical Instruments & Apparatus), by market cap.

P/E vs peers
23.27 / 28.73 med
-19% discount
P/S vs peers
3.35 / 2.52 med
+33% premium
Net margin vs peers
14.4% / -7.6% med
above median
1–14 of 14
SYKStryker Corporation$118.1B36.384.7012.9%+2.28%
MMM3M$83.9B25.823.3613.0%+1.10%
BSXBoston Scientific$67.3B23.273.3514.4%+0.64%
BDXBecton Dickinson$39.7B23.641.827.7%+1.62%
MDLNMedline Inc.$29.4B-1.47%
DXCMDexCom$28.0B33.436.0017.9%+1.69%
RMDResMed$27.4B19.535.3227.2%+1.24%
WSTWest Pharmaceutical Services$23.2B46.927.5416.1%+1.35%
SOLVSolventum$13.1B+1.21%
PENPenumbra Inc$12.5B70.188.8812.7%+0.28%
GMEDGlobus Medical Inc$10.8B19.993.6618.3%+5.00%
BAXBaxter International$10.3B-10.740.91-8.5%+2.58%
PODDInsulet Corporation$10.1B40.843.739.1%+1.51%
GKOSGlaukos Corp$7.7B-40.9215.13-37.0%+2.53%

Source: SEC EDGAR (fundamentals/EPS/dividends) · Databento EQUS.MINI (prices) · market cap & yield computed by tradmap. Informational only — not financial advice.